Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Comment by PSBon Oct 23, 2012 9:27pm
183 Views
Post# 20516101

RE: RE: RE: Market down badly today

RE: RE: RE: Market down badly today

Thecat777,

I read this BNC board all the time but rarely post on it. There is a lot of very informative posts and posters on here but also a lot of multiple alias bashers and pumpers for that matter, who are very obvious. I am not going to get into naming the names as I am sure you can figure out who most of them are. I enjoy reading your posts for the most part and do disagree with some of the negative comments towards you, however you are totally wrong about Zep misreading or misunderstanding last week's Bioniche press realease on the Immunocidin launch. As far as I can tell, all he was questioning and seemed confused by was, they said the exact opposite in the July press release.  Infact, that confused me as well when I first read this latest Immunocidin release about US first and canada later this year. They said the exact opposite in the July press release. Very confusing to say the least.

" The Company has received approval from regulators in both Canada and the USA for Immunocidin™, the first of its two canine oncology products. Bioniche has begun market launch activities and the product is expected to be available in Canada in September 2012, with a U.S. launch before the end of the year".

Bullboard Posts